Tirzepatide is a newer dual GLP-1 and GIP receptor agonist approved by the FDA in 2022, representing the next evolution after single GLP-1 drugs
(PubMed) Dy SM, Bennett WL, Sharma R, et al
Its chemical structure is: Empirical Formula: C7H15NO3 Molecular Weight: 161.20 g/mol Levocarnitine injection, USP is a clear, colorless sterile solution containing 1 g of levocarnitine, USP per 5 mL vial and water for injection
Key properties: Does not increase cortisol important for avoiding stress hormone elevation Does not increase prolactin no hormonal disruption Minimal ghrelin-like hunger suitable when appetite stimulation is unwanted Dose-dependent GH release predictable, linear response This selectivity makes Ipamorelin the go-to choice when a clean GH pulse is the primary goal without metabolic side effects
This review delves into the pathogenesis of diabetes mellitus and CKD, highlighting the unique challenges these complications present in liver transplant recipients